- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Mirabegron
Total 167 results
-
Astellas Pharma Singapore Pte. Ltd.CompletedOveractive Bladder (OAB)Korea, Republic of, Taiwan
-
Southern Illinois UniversityAstellas Scientific & Medical Affairs, Inc.; Sisters of the Third Order of...CompletedLower Urinary Tract Symptoms | NocturiaUnited States
-
National Institute of Diabetes and Digestive and...RecruitingHealthy VolunteersUnited States
-
Henning BundgaardHvidovre University Hospital; Herlev Hospital; Royal North Shore Hospital; Bispebjerg-Frederiksberg... and other collaboratorsCompletedHeart Failure With Reduced Ejection Fraction NYHA Class III-IVDenmark
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
Astellas Pharma Singapore Pte. Ltd.CompletedOveractive Bladder (OAB)Korea, Republic of, Australia
-
Southern Illinois UniversityAstellas Scientific & Medical Affairs, Inc.; Sisters of the Third Order of...TerminatedPain | Urinary Bladder, Overactive | Lower Urinary Tract SymptomsUnited States
-
The University of Texas Health Science Center at...CompletedCognitive Change | Spinal Cord Injuries | Neurogenic BladderUnited States
-
Loyola UniversityAstellas Pharma US, Inc.Completed
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveJapan
-
Astellas Pharma IncCompletedOveractive Bladder | Cardiovascular DiseaseJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedIntraocular PressureUnited States
-
Philip KernNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Philadelphia Urosurgical AssociatesAstellas Pharma Global Development, Inc.TerminatedCystitis, InterstitialUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States, Canada
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States, Hungary, Canada, Spain, Finland, Slovakia, Czechia, Sweden, Germany, Denmark, Norway
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Canada
-
Theodore R. Brown, MD MPHAstellas Pharma IncCompletedMultiple SclerosisUnited States
-
Baylor College of MedicineCompletedUreteral Obstruction | Flank PainUnited States
-
Daniel Burdick, MDAstellas Pharma US, Inc.Completed
-
Henning BundgaardCompletedChronic Heart Failure With Reduced Ejection Fraction (HFrEF)Australia, Denmark
-
Astellas Pharma Global Development, Inc.TerminatedPharmacokinetics of Mirabegron | Overactive Bladder (OAB)Korea, Republic of, Russian Federation, Turkey
-
University of California, San DiegoRecruiting
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
-
Seoul National University HospitalUnknownOveractive Bladder | Parkinson DiseaseKorea, Republic of
-
National Institute of Diabetes and Digestive and...RecruitingPolycystic Ovary SyndromeUnited States
-
Dong-A ST Co., Ltd.CompletedHealthyKorea, Republic of
-
Astellas Pharma IncCompletedPharmacokinetics of YM178United States
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urgency Incontinence | Urinary Bladder OveractiveCzechia, Denmark, Greece, Ireland, Slovakia, Spain, Sweden, United Kingdom
-
Lawson Health Research InstituteTerminatedUrinary Bladder, NeurogenicCanada
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Christopher BellIndiana UniversityActive, not recruitingThermoregulationUnited States
-
Genuine Research Center, EgyptMulti-Apex PharmaCompleted
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingOveractive Bladder | Urinary Incontinence | Urinary Incontinence, Urge | Incontinence | Incontinence, Urinary | Incontinence, UrgeUnited States
-
Elsayed Abdelhalim ElsayedCompleted
-
University of California, San FranciscoCompletedUrge Incontinence | Urinary Incontinence, UrgeUnited States
-
Astellas Pharma IncAstellas Pharma Singapore Pte. Ltd.Completed
-
Instituto Valenciano de Infertilidad, IVI VALENCIACompleted
-
Astellas Pharma Europe B.V.Completed
-
St. Joseph's Healthcare HamiltonNot yet recruitingOveractive Bladder | Benign Prostatic HyperplasiaCanada
-
Kafrelsheikh UniversityCompletedNausea | Vomiting of PregnancyEgypt
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Astellas Pharma Europe B.V.CompletedUrologic Diseases | Urinary Bladder, Overactive | Urinary Bladder Diseases | Urological Manifestations | Signs and SymptomsBelarus, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine, United Kingdom
-
Boryung Pharmaceutical Co., LtdCompletedA Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.Overactive Bladder | Benign Prostatic Hyperplasia (BPH)Korea, Republic of
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder | Benign Prostatic HyperplasiaUnited States, Canada, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation...UnknownSpinal Cord Injuries | Urinary Bladder, NeurogenicUnited States